1
|
Wijers A, Ravi A, Evers SMAA, Tissingh G, van Mastrigt GAPG. Systematic Review of the Cost of Illness of Parkinson's Disease from a Societal Perspective. Mov Disord 2024. [PMID: 39221849 DOI: 10.1002/mds.29995] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2024] [Revised: 07/19/2024] [Accepted: 08/07/2024] [Indexed: 09/04/2024] Open
Abstract
Previous reviews on the cost of illness (COI) of Parkinson's disease (PD) have often focused on health-care costs due to PD, underestimating its effects on other sectors. This systematic review determines the COI of PD from a societal perspective. The protocol was registered in PROSPERO (ID: CRD42023428937). Embase, Medline, and EconLit were searched up to October 12, 2023, for studies determining the COI of PD from a societal perspective. From 2812 abstracts, 17 studies were included. The COI of PD averaged €20,911.37 per patient per year, increasing to almost €100,000 in the most severely affected patients. Health-care costs accounted for 46.1% of total costs, followed by productivity loss (37.4%) and costs to patient and family (16.4%). The COI of PD strongly varied between different geographical regions, with costs in North America 3.6 times higher compared to Asia. This study is the first to identify the relative importance of different cost items. Most important were reduced employment, government benefits, informal care, medication, nursing homes, and hospital admission. There was strong variety in the cost items that were included, with 55.2% of cost items measured in fewer than half of articles. Our review shows that PD-COI is high and appears in various cost sectors, with strong variety in the cost items included in different studies. Therefore, a guideline for the measurement of COI in PD should be developed to harmonize this. This article provides a first step toward the development of such a tool by identifying which cost items are most relevant. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Collapse
Affiliation(s)
- Anke Wijers
- Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht UniversityMaastricht, The Netherlands
- Department of Neurology, Zuyderland Medical Centre, Heerlen, The Netherlands
| | - Anirudhan Ravi
- Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht UniversityMaastricht, The Netherlands
| | - Silvia M A A Evers
- Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht UniversityMaastricht, The Netherlands
- Centre of Economic Evaluation, Trimbos Institute, Institute of Mental Health and Addictions, Utrecht, The Netherlands
| | - Gerrit Tissingh
- Department of Neurology, Zuyderland Medical Centre, Heerlen, The Netherlands
| | - Ghislaine A P G van Mastrigt
- Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht UniversityMaastricht, The Netherlands
| |
Collapse
|
2
|
Jain N, Wijnen B, Lohumi I, Chatterjee S, Evers SMAA. Economic burden of suicides and suicide attempts in low- and middle-income countries: a systematic review of costing studies. Expert Rev Pharmacoecon Outcomes Res 2024:1-13. [PMID: 39099300 DOI: 10.1080/14737167.2024.2388132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2023] [Revised: 06/25/2024] [Accepted: 07/31/2024] [Indexed: 08/06/2024]
Abstract
INTRODUCTION Suicide is a major public health concern in low- and middle-income countries (LMICs) due to its substantial psychological, social, and economic impact. There is little synthesized evidence to estimate the economic burden of suicide and suicide attempts in such economies. The present systematic literature review aims to examine existing evidence on the cost of illness (COI) in the case of suicides and suicide attempts and assess their quality. METHODS A systematic review was carried out using electronic databases, such as Medline, EMBASE, EconLit, PsycINFO, and CINAHL using keywords like 'suicide and suicide attempts,' 'cost of illness,' and economic burden." The quality assessment of studies was conducted along with the per-person cost estimation to understand the variation of methods followed across the studies. RESULT 14 studies qualified for final data extraction and synthesis out of 4,164 studies. The studies showed heterogeneity across objectives, settings, and methods, with cost estimates reflecting a wide range of costings per person in suicide and suicide attempts. CONCLUSION It is challenging to determine and compare the economic estimates of suicide. Intensive research is warranted with standardized cost assessment techniques and wider perspectives to understand the true economic burden of suicide. REGISTRATION PROSPERO Registration No- CRD42022294080.
Collapse
Affiliation(s)
- Nikhil Jain
- Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
- Centre for Mental Health, Law and Policy, Indian Law Society, Pune, India
| | - Ben Wijnen
- Centre for Economic Evaluations and Machine Learning, Trimbos Institute, Utrecht, The Netherlands
| | - Isha Lohumi
- Centre for Mental Health, Law and Policy, Indian Law Society, Pune, India
| | | | - Silvia M A A Evers
- Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
- Centre for Economic Evaluations and Machine Learning, Trimbos Institute, Utrecht, The Netherlands
| |
Collapse
|
3
|
Johnson EE, Searle B, Lazo Green K, Walbaum M, Barker R, Brotherhood K, Spiers GF, Craig D, Hanratty B. Interventions to Prevent Hospital Admissions in Long-Term Care Facilities: A Rapid Review of Economic Evidence. J Am Med Dir Assoc 2024; 25:105034. [PMID: 38796166 DOI: 10.1016/j.jamda.2024.105034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2024] [Revised: 04/08/2024] [Accepted: 04/10/2024] [Indexed: 05/28/2024]
Abstract
OBJECTIVES Hospital admissions can be hazardous for older adults, particularly those living in long-term care facilities. Preventing nonessential admissions can be beneficial for this population, as well as reducing demand on health services. This review summarizes the economic evidence surrounding effective interventions to reduce hospital attendances and admissions for people living in long-term care facilities. DESIGN Rapid review of economic evidence. SETTING AND PARTICIPANTS People living in long-term facilities. METHODS We searched MEDLINE, CINAHL, Cochrane CENTRAL, PubMed, and Web of Science on September 20, 2022, and again on January 10, 2023. Full economic evaluations and cost analyses reporting on advanced care planning, goals of care setting, nurse practitioner input, palliative care, influenza vaccinations, and enhancing access to intravenous therapies were eligible. Data were extracted using a prepiloted data extraction form and critically appraised using either the Drummond-Jefferson checklist or an amended NIH Critical Appraisal Tool appended with questions from a critical appraisal checklist for cost analyses. Data were synthesized narratively. RESULTS We included 7 studies: 3 full economic evaluations and 4 cost analyses. Because of lack of clarity on the underlying study design, we did not include one of the cost analyses in our synthesis. Advanced care planning, a palliative care program, and a high-dose influenza vaccination reported potential cost savings. Economic evidence for a multicomponent intervention and a nurse practitioner model was inconclusive. The overall quality of the evidence varied between studies. CONCLUSIONS AND IMPLICATIONS A number of potentially cost-effective approaches to reduce demand on hospital services from long-term care facilities were identified. However, further economic evaluations are needed to overcome limitations of the current evidence base and offer more confident conclusions.
Collapse
Affiliation(s)
- Eugenie E Johnson
- Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; NIHR Innovation Observatory, Newcastle University, Newcastle upon Tyne, United Kingdom
| | - Ben Searle
- Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
| | - Kimberly Lazo Green
- School of Health Sciences, University of Manchester, Manchester, United Kingdom
| | - Magdalena Walbaum
- Care Policy and Evaluation Centre, London School of Economics and Political Science, London, United Kingdom
| | - Robert Barker
- Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
| | - Kelly Brotherhood
- Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
| | - Gemma Frances Spiers
- Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
| | - Dawn Craig
- Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; NIHR Innovation Observatory, Newcastle University, Newcastle upon Tyne, United Kingdom
| | - Barbara Hanratty
- Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
| |
Collapse
|
4
|
Yeong SW, Lee SW, Ong SC. Cost of illness of breast cancer in low- and middle-income countries: a systematic review. HEALTH ECONOMICS REVIEW 2024; 14:56. [PMID: 39034345 PMCID: PMC11264967 DOI: 10.1186/s13561-024-00536-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/19/2023] [Accepted: 07/15/2024] [Indexed: 07/23/2024]
Abstract
This systematic review explores the cost of illness (COI) studies on breast cancer in low- to middle-income countries (LMICs). Studies in Cochrane, Proquest Thesis, PubMed and Scopus were considered. The reporting criteria were evaluated using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 statement. Studies must (1) be peer-reviewed, (2) report cost data, and (3) be full-text articles. Non-English articles were excluded. Twelve studies were included. The identified costs were made constant to 2022 USD values for reporting and comparison across studies. Annual costs per patient varied from $195 to $11,866 direct medical costs, $201 to $2233 direct non-medical costs and $332 to $26,390 productivity losses were reported. Cost differences were due to the cost types and components in each study. Only three COI studies reported sensitivity analysis and discount rates. Hence, it is recommended that future COI studies include an analysis of correlation between cost components and other variables.
Collapse
Affiliation(s)
- Siew Wei Yeong
- School of Pharmaceutical Sciences, Universiti Sains Malaysia, Georgetown, Penang, Malaysia
| | - Sit Wai Lee
- Malaysian Health Technology Assessment Section, Medical Development Division, Ministry of Health Malaysia, Putrajaya, Malaysia
| | - Siew Chin Ong
- School of Pharmaceutical Sciences, Universiti Sains Malaysia, Georgetown, Penang, Malaysia.
| |
Collapse
|
5
|
Bezerra IL, Nassar Junior AP, Dos Santos TM, Tomazini BM, Veiga VC, Arns B, Nascimento GM, Cavalcanti AB, Malheiro DT, Pereira AJ. Patient-level cost analysis of intensive care unit acquired infections: A prospective cohort study. J Hosp Infect 2024:S0195-6701(24)00251-2. [PMID: 39032569 DOI: 10.1016/j.jhin.2024.07.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2024] [Revised: 07/04/2024] [Accepted: 07/08/2024] [Indexed: 07/23/2024]
Abstract
INTRODUCTION Hospital-associated infections (HAIs) are associated with increased mortality and prolonged hospital length-of-stay (LOS). Although some studies have shown that HAIs are associated with increased costs, these studies only used cost estimates, were carried out in a small number of centres, or only in high-income countries. METHODS We carried out a prospective cohort study in ten Brazilian intensive care units (ICUs) selected from a collaborative platform study (IMPACTO MR). We included all patients aged 18 years or older admitted from October 2019 to December 2021 and who had an ICU LOS of at least two days. The costs were adjusted for official inflation until December 2022 and converted into international dollars using the 2021 purchasing power parity (PPP) conversion rate. We used a propensity score matching method to compare patients with HAIs and patients without HAIs, and patients with and without ventilator-associated pneumonia (VAP), central-line bloodstream infection (CLABSI), catheter-associated urinary tract infection (CA-UTI) and multidrug-resistant (MDR) HAIs. RESULTS We included 7,953 patients in the study, of whom 574 (7.2%) had an HAI during their ICU stay. After propensity-score matching, patients with HAIs had ICU costs that were more than three times higher than those of patients without HAIs [$ 19,642 (IQR; 12,884-35,134) vs. 6,086 (IQR; 3,268-12,550); p <0.001). Patients with VAP, CLABSI, and CA-UTI, but not with MDR-HAIs also had higher total ICU costs. CONCLUSIONS HAIs acquired in the ICU are associated with higher ICU costs. These findings were consistent across specific types of infection.
Collapse
Affiliation(s)
- Isabella Lott Bezerra
- Big Data, Program to Support the Institutional Development of the Unified Health System (PROADI-SUS), Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
| | - Antonio Paulo Nassar Junior
- Big Data, Program to Support the Institutional Development of the Unified Health System (PROADI-SUS), Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
| | - Tiago Mendonça Dos Santos
- Big Data, Program to Support the Institutional Development of the Unified Health System (PROADI-SUS), Hospital Israelita Albert Einstein, São Paulo, SP, Brazil; Insper Institute of Education and Research, São Paulo, Brazil
| | - Bruno Martins Tomazini
- Program to Support the Institutional Development of the Unified Health System (PROADI-SUS), Research Institute, HCor, São Paulo, SP, Brazil; Program to Support the Institutional Development of the Unified Health System (PROADI-SUS), Hospital Sírio-Libanês, São Paulo, SP, Brazil
| | - Viviane Cordeiro Veiga
- Program to Support the Institutional Development of the Unified Health System (PROADI-SUS), BP - A Beneficência Portuguesa de São Paulo, São Paulo, SP, Brazil
| | - Beatriz Arns
- Program to Support the Institutional Development of the Unified Health System (PROADI-SUS), Hospital Moinhos de Vento, Porto Alegre, RS, Brazil
| | - Giovanna Marssola Nascimento
- Program to Support the Institutional Development of the Unified Health System (PROADI-SUS), Oswaldo Cruz, São Paulo, SP, Brazil
| | - Alexandre Biasi Cavalcanti
- Program to Support the Institutional Development of the Unified Health System (PROADI-SUS), Research Institute, HCor, São Paulo, SP, Brazil
| | - Daniel Tavares Malheiro
- Big Data, Program to Support the Institutional Development of the Unified Health System (PROADI-SUS), Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
| | - Adriano José Pereira
- Big Data, Program to Support the Institutional Development of the Unified Health System (PROADI-SUS), Hospital Israelita Albert Einstein, São Paulo, SP, Brazil; Post-graduation Program, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
| |
Collapse
|
6
|
Das N, Nguyen P, Ho TQA, Lee P, Robinson S, Gao L. Methods for Measuring and Valuing Informal Care: A Systematic Review and Meta-Analysis in Stroke. VALUE IN HEALTH : THE JOURNAL OF THE INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH 2024:S1098-3015(24)02746-3. [PMID: 38977195 DOI: 10.1016/j.jval.2024.06.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/06/2023] [Revised: 05/09/2024] [Accepted: 06/30/2024] [Indexed: 07/10/2024]
Abstract
OBJECTIVES To accurately capture informal care in healthcare evaluations, rigorous approaches are required to measure and value this important care component. In this systematic review and meta-analysis, we intended to summarize the current methods of measuring and valuing informal care costs in healthcare evaluations (full and partial healthcare evaluations, including cost of illness and cost analysis) in stroke. METHODS A systematic search was conducted in MEDLINE, Embase, EconLit, and CINAHL. We used EndNote 20, Research Screener, and Covidence platforms for screening and data extraction. A meta-analysis was performed on informal care hours, and a subgroup meta-analysis was conducted based on stroke severity. RESULTS A total of 31 articles were included in the qualitative synthesis. There was variation among the studies in the informal care measurement and valuation approaches. The meta-analysis of studies where data on informal care hours were available showed an estimate of informal care hours of 25.76 per week (95% CI 13.36-38.16) with a high heterogeneity (I2 = 99.97%). The overall risk of bias in the studies was assessed as low. CONCLUSIONS Standardizing the measurement and valuation of informal care costs is essential for improving the consistency and comparability of economic evaluations. Pilot studies that incorporate standardized informal care cost valuation methods can help identify any practical challenges and capture the impact of informal care more accurately.
Collapse
Affiliation(s)
- Neha Das
- Faculty of Health, School of Health & Social Development, Institute for Health Transformation, Deakin University, Melbourne Burwood Campus, Melbourne, VIC, Australia.
| | - Phuong Nguyen
- Faculty of Health, School of Health & Social Development, Institute for Health Transformation, Deakin University, Melbourne Burwood Campus, Melbourne, VIC, Australia
| | - Thi Quynh Anh Ho
- Faculty of Health, School of Health & Social Development, Institute for Health Transformation, Deakin University, Melbourne Burwood Campus, Melbourne, VIC, Australia
| | - Peter Lee
- Faculty of Health, School of Health & Social Development, Institute for Health Transformation, Deakin University, Melbourne Burwood Campus, Melbourne, VIC, Australia
| | - Suzanne Robinson
- Faculty of Health, School of Health & Social Development, Institute for Health Transformation, Deakin University, Melbourne Burwood Campus, Melbourne, VIC, Australia
| | - Lan Gao
- Faculty of Health, School of Health & Social Development, Institute for Health Transformation, Deakin University, Melbourne Burwood Campus, Melbourne, VIC, Australia
| |
Collapse
|
7
|
Haile TG, Pereira G, Norman R, Tessema GA. Economic burden of adverse perinatal outcomes from births to age 5 years in high-income settings: a protocol for a systematic review. BMJ Open 2024; 14:e079077. [PMID: 38216187 PMCID: PMC10806659 DOI: 10.1136/bmjopen-2023-079077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Accepted: 12/07/2023] [Indexed: 01/14/2024] Open
Abstract
BACKGROUND Adverse perinatal outcomes such as preterm, small for gestational age, low birth weight, congenital anomalies, stillbirth and neonatal death have devastating impacts on individuals, families and societies, with significant lifelong health implications. Despite extensive knowledge of the significant and lifelong health implications of adverse perinatal outcomes, information on the economic burden is limited. Estimating this burden will be crucial for designing cost-effective interventions to reduce perinatal morbidity and mortality. Thus, we will quantify the economic burden of adverse perinatal outcomes from births to age 5 years in high-income countries. METHODS AND ANALYSIS A systematic review of all primary studies published in English in peer-reviewed journals on the economic burden for at least one of the adverse perinatal outcomes in high-income countries from 2010 will be searched in databases-MEDLINE (Ovid), EconLit, CINAHL (EBSCO), Embase (Ovid) and Global Health (Ovid). We will also search using Google Scholar and snowballing of the references list of included articles. The search terms will include three main concepts-costs, adverse perinatal outcome(s) and settings. We will use the Consolidated Health Economics Evaluation Reporting Standards 2022 and 17 criteria from the critical appraisal of cost-of-illness studies to assess the quality of each study. We will report the findings based on the Preferred Reporting Items for Systematic Reviews and Meta-analyses 2020 statement. Costs will be converted into a common currency (US dollar), and we will estimate the pooled cost and subgroup analysis will be done. The reference lists of included papers will be reviewed. ETHICS AND DISSEMINATION This systematic review will not involve human participants and requires no ethical approval. The results of this review will be published in a peer-reviewed journal. PROSPERO REGISTRATION NUMBER CRD42023400215.
Collapse
Affiliation(s)
- Tsegaye Gebremedhin Haile
- Curtin School of Population Health, Curtin University, Perth, Western Australia, Australia
- Department of Health Systems and Policy, Institute of Public Health, University of Gondar, Gondar, Ethiopia
| | - Gavin Pereira
- Curtin School of Population Health, Curtin University, Perth, Western Australia, Australia
- enAble Institute, Curtin University, Perth, Western Australia, Australia
| | - Richard Norman
- Curtin School of Population Health, Curtin University, Perth, Western Australia, Australia
- enAble Institute, Curtin University, Perth, Western Australia, Australia
| | - Gizachew A Tessema
- Curtin School of Population Health, Curtin University, Perth, Western Australia, Australia
- enAble Institute, Curtin University, Perth, Western Australia, Australia
- School of Public Health, University of Adelaide, Adelaide, South Australia, Australia
| |
Collapse
|